Utilization of Quantiferon-Cytomegalovirus Assay to Assess the Risk of CMV Disease and Guide Duration of Antiviral Prophylaxis in CMV-Mismatched Solid Organ Transplant Recipients
Open Forum Infectious Diseases | February 2, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available
10.1093/ofid/ofw172.1841